🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10257+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10257 recruiting trials

NARecruitingNCT07104084

Influence of Antiseptic Washes on Wound Healing Complications After THA

👨‍⚕️ Frank J Plate, MD, PhD, University of Pittsburgh📍 2 sites📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT06997588

EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)

👨‍⚕️ Novartis Pharmaceuticals, Novartis Pharmaceuticals📍 22 sites📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT06529718

Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients

👨‍⚕️ Julien Edeline, MD, Centre Eugène Marquis📍 3 sites📅 Started Oct 2025View details ↗
NARecruitingNCT07484607

Understanding Inflammation, InFection and Interventions in Severe Exacerbations of Cystic Fibrosis

👨‍⚕️ Alexander Horsley, MA MBChB MRCP PhD FERS📍 6 sites📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT07132918

HEARTS Trial for Thoracic Cancers

👨‍⚕️ Carri Glide-Hurst, PhD, DABR, FAAPM, University of Wisconsin, Madison📍 1 site📅 Started Oct 2025View details ↗
Phase 1RecruitingNCT07107490

A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER

👨‍⚕️ Sponsor Chugai Pharmaceutical Co.Ltd, clinical-trials@chugai-pharm.co.jp📍 6 sites📅 Started Oct 2025View details ↗
Phase 1RecruitingNCT07200596

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy Subjects

🏥 Guangdong Hengrui Pharmaceutical Co., Ltd📍 1 site📅 Started Oct 2025View details ↗
Phase 4RecruitingNCT07356778

A Study of Sotatercept for Patients With Eisenmenger Syndrome or Unrepaired Shunt-Associated Pulmonary Arterial Hypertension Resistant to Vasodilator Therapy

🏥 Kazuya Hosokawa📍 10 sites📅 Started Oct 2025View details ↗
NARecruitingNCT07457463

Evaluation of the Pulmonary Fibrosis Learning and Self-management Programme (FILIP)

👨‍⚕️ Thimo Marcin, PHD, Center for Rehabilitation & Sports Medicine Inselspital and Berner Reha Zentrum, Bern University Hospital, University of Bern, Switzerland📍 2 sites📅 Started Oct 2025View details ↗
Phase 3RecruitingNCT07166406

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

🏥 NRG Oncology📍 83 sites📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT07023666

Early Screening and Treatment of Heart Complication in Sickle Cell Disease

👨‍⚕️ Sheinei Alan, MD, Inova Fairfax Hospital📍 2 sites📅 Started Oct 2025View details ↗
Phase 4RecruitingNCT07219121

Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis

👨‍⚕️ Radko Komers, MD, PhD, Travere Therapeutics📍 9 sites📅 Started Oct 2025View details ↗
Phase 1RecruitingNCT07116057

MOv19-BBz CAR T Cells in FRa+ Cancers

👨‍⚕️ Andrew Haas, MD, PhD, University of Pennsylvania📍 1 site📅 Started Oct 2025View details ↗
Phase 1, PHASE2RecruitingNCT07070219

A Study of CTD402 in T-ALL/LBL Patients

🏥 BIOHENG THERAPEUTICS US LLC📍 8 sites📅 Started Oct 2025View details ↗
Phase 1, PHASE2RecruitingNCT06988488

A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma

👨‍⚕️ Bristol-Myers Squibb, Bristol-Myers Squibb📍 22 sites📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT06649812

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

👨‍⚕️ Christopher J Melani, ECOG-ACRIN Cancer Research Group📍 70 sites📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT07205731

Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell Carcinoma

🏥 University Hospital, Clermont-Ferrand📍 24 sites📅 Started Oct 2025View details ↗
Phase 4RecruitingNCT07140484

Sotatercept in Pulmonary Arterial Hypertension

👨‍⚕️ Jason Weatherald, MD, University of Alberta📍 1 site📅 Started Oct 2025View details ↗
Phase 1RecruitingNCT05630794

Testing for Safety and Colorectal Cancer Preventive Effects of ONC201

👨‍⚕️ Alexander G Raufi, MD, Brown University Health/ Rhode Island Hospital📍 5 sites📅 Started Oct 2025View details ↗
NAEnrolling by InvitationNCT07495410

Anderson-Fabry Disease Fitness Improvement Training: A-FAD-FIT

🏥 General University Hospital, Prague📍 1 site📅 Started Oct 2025View details ↗
← PreviousPage 57 of 513Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →